Opinion|Videos|August 1, 2024
Unmet Needs in IPF Landscape
Author(s)Justin Oldham, MD, MS
Critical voids in the management of idiopathic pulmonary fibrosis are discussed by Justin Oldham, MD, MS.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are the current unmet needs in IPF treatment and why is it necessary to develop new pharmacotherapies for this disease?
- What biomarkers are currently used for the diagnosis of IPF?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
5 Things to Know About the Oral GLP-1 Era
5
